Do Myelin Oligodendrocyte Glycoprotein Antibodies Represent a Distinct Syndrome?

Update item information
Title Do Myelin Oligodendrocyte Glycoprotein Antibodies Represent a Distinct Syndrome?
Creator John J. Chen, Clare L. Fraser
Affiliation Mayo Clinic (JJC), Rochester, Minnesota; and Save Sight Institute (CLF), Faculty of Health and Medicine, The University of Sydney, Sydney, Australia
Abstract Myelin oligodendrocyte glycoprotein (MOG-IgG) antibodies have been associated with a variety of demyelinating neurologic disorders, including optic neuritis. It remains unclear whether the presence of MOG-IgG represents a distinct syndrome or is simply a marker for central demyelination. Two experts, John J. Chen, MD, PhD, and Clare L. Fraser, MBBS, MMed, debate this topic.
OCR Text Show
Publisher Lippincott, Williams & Wilkins
Date 2019-09
Type Text
Source Journal of Neuro-Ophthalmology, September 2019, Volume 39, Issue 3
Language eng
Rights Management © North American Neuro-Ophthalmology Society
Publication Type Journal Article
ARK ark:/87278/s62z6w0t
Setname ehsl_novel_jno
Date Created 2020-09-25
Date Modified 2021-05-06
ID 1595904
Reference URL https://collections.lib.utah.edu/ark:/87278/s62z6w0t
Back to Search Results